Sort
51,593 grants matching “hepatitis”
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2018 · DK
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2017 · DK
A single antiviral to treat multiple opportunistic infections
$1,000,000Stacy Remiszewski · Evrys Bio, Llc · R44 · FY2021 · AI
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$1,000,000Paul Joseph Utz · Stanford University · R01 · FY2016 · AI
Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II
$1,000,000Brian S Murphy · Eiger Group International, Inc. · R42 · FY2013 · AI
CDC Racial and Ethnic Approaches to Community Health Across the US
$1,000,000National Institute On Minority Health And Health Disparities · Y01 · FY2010 · MD
Liver Center
$1,000,000Jacquelyn J. Maher · University Of California, San Francisco · P30 · FY2006 · DK
High Tc susceptometer for magnetic measure of body iron
$1,000,000Columbia University Health Sciences · R01 · FY2001 · DK
DIGESTIVE DISEASES RESEARCH CORE CENTERS
$1,000,000Yale University · P30 · FY2001 · DK
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$1,000,000Paul Joseph Utz · Stanford University · R01 · FY2019 · AI
Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection
$1,000,000Andrea Cuconati · Pharmabridge, Inc. · R44 · FY2011 · AI
IGF::OT::IGF HIGH AFFINITY SISCAPA ANTIBODIES
$1,000,000Donghui Ma · Origene Technologies, Inc. · N44 · FY2015 · CA
Preclinical development of capsid assembly modulators for the treatment of chronic hepatitis B virus infection
$1,000,000Glen Andrew Coburn · Venatorx Pharmaceuticals, Inc. · R44 · FY2023 · AI
Childhood Liver Disease Research Network (ChiLDReN) Scientific and Data Coordinating Center
$1,000,000John C Magee · University Of Michigan At Ann Arbor · U24 · FY2024 · DK
Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients
$1,000,000Nathan Allan Stasko · Vast Therapeutics, Inc. · R44 · FY2025 · AI
Endovascular ChemoFilter to Reduce Doxorubicin Toxicity during Intra-Arterial Chemotherapy
$1,000,000Steven William Hetts · Filtro Medical Inc. · R42 · FY2023 · CA
Recombinant yeast vaccines for sensitive and drug-resistant M. tuberculosis
$1,000,000Timothy Rodell · Globeimmune, Inc. · R01 · FY2015 · AI
Liver Center
$1,000,000University Of California San Francisco · P30 · FY2005 · DK
Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II
$1,000,000Brian S Murphy · Eiger Group International, Inc. · R42 · FY2011 · AI
Advancing clemizole for hepatitis C: towards a pre-IND package--Phase II
$1,000,000Brian S Murphy · Eiger Group International, Inc. · R42 · FY2012 · AI
Liver Center
$1,000,000University Of California San Francisco · P30 · FY2004 · DK
A Multi-Center Group to Study Acute Liver Failure
$1,000,000William M Lee · Ut Southwestern Medical Center · U01 · FY2019 · DK
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$1,000,000Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2023 · AI
LIVER CENTER
$1,000,000University Of California San Francisco · P30 · FY2000 · DK
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.
$1,000,000Nhi Khuong · Lumen Bioscience, Inc. · R42 · FY2021 · AI